[Elsevier] Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study |
|
This post will be closed automatically in 2026-06-10 08:59
Reward20points
|
10
Metformin〞mechanisms of its glycemia-reducing effect
10
How does authentic leadership drive hotel employees to innovate? A cross-level influencing process
10
Carotid Plaque-Burden scale and outcomes: A real-life study
10
Agricultural subsidies on common prosperity: Evidence from the Chinese social survey
10
Small molecule LpxC inhibitors against gram-negative bacteria: Advances and future perspectives
